RECOVER-TLC to host next webinar March 26, 2026
NIH and FNIH leaders will discuss how RECOVER-TLC continues to advance toward Long COVID clinical trials.
The National Institute of Allergy and Infectious Diseases (NIAID) and the Foundation for the National Institutes of Health (FNIH) will host the next RECOVER-Treating Long COVID (RECOVER-TLC) webinar on Thursday, March 26, 2026, from 1:00-2:00 pm ET. Featured speakers will include Acting NIAID Director Jeffery K. Taubenberger, MD, PhD, and FNIH President and CEO Julie L. Gerberding, MD, MPH.
During this online event, Dr. Taubenberger, Dr. Gerberding, and others will explain how RECOVER-TLC is overcoming challenges with the design of its first 4 clinical trials. These trials include REVERSE-LC, which is currently enrolling at 17 study sites across the US.
The webinar will also include a question-and-answer session. Anyone is welcome to submit comments and questions in advance.
Register for the March 26 webinar.
Following the webinar, a recording will be available on the FNIH website.